Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
PHASE1
RATIONALE: Diagnostic procedures, such as positron emission tomography, usi...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
PHASE1
This phase I trial is studying the side effects of fluorine F18 EF5 when gi...
Status
Terminated
Location
Abramson Cancer Center of The University of Pennsylvania
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx
NA
Rationale: Diagnostic procedures, such as positron emission tomography, usi...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania